TrialClinical lymphoma, myeloma & leukemia2020

SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes.

Qing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.